BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 25644744)

  • 1. ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia.
    Gallagher KM; Roderick JE; Tan SH; Tan TK; Murphy L; Yu J; Li R; O'Connor KW; Zhu J; Green MR; Sanda T; Kelliher MA
    Blood Adv; 2020 Jul; 4(13):3154-3168. PubMed ID: 32658986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hair cortisol, glucocorticoid gene receptor polymorphisms, stress, and testicular function.
    Nordkap L; Almstrup K; Priskorn L; Bang AK; Stalder T; Petersen JH; Hansen ÅM; Juul A; Johannsen TH; Jørgensen N
    Psychoneuroendocrinology; 2022 Dec; 146():105942. PubMed ID: 36179533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
    Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
    Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of folate pathway and DNA repair polymorphisms with susceptibility to childhood acute lymphoblastic leukemia.
    Goričar K; Erčulj N; Faganel Kotnik B; Debeljak M; Hovnik T; Jazbec J; Dolžan V
    Gene; 2015 May; 562(2):203-9. PubMed ID: 25746326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.
    Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y
    Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment.
    Eckert C; Hagedorn N; Sramkova L; Mann G; Panzer-Grümayer R; Peters C; Bourquin JP; Klingebiel T; Borkhardt A; Cario G; Alten J; Escherich G; Astrahantseff K; Seeger K; Henze G; von Stackelberg A
    Leukemia; 2015 Aug; 29(8):1648-55. PubMed ID: 25748682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving access to novel agents for childhood leukemia.
    Sun W; Gaynon PS; Sposto R; Wayne AS
    Cancer; 2015 Jun; 121(12):1927-36. PubMed ID: 25678105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance.
    Zhang XJ; Zhao PX; Ma MS; Wu H; Liu R; Wang H; Liu MY; Xie F; Ma XM
    Int J Ophthalmol; 2023; 16(11):1734-1745. PubMed ID: 38028530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells.
    Shinohara T; Urayama KY; Watanabe A; Akahane K; Goi K; Huang M; Kagami K; Abe M; Sugita K; Okada Y; Goto H; Minegishi M; Iwamoto S; Inukai T
    J Cell Mol Med; 2020 Nov; 24(22):12920-12932. PubMed ID: 33002292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia.
    Follini E; Marchesini M; Roti G
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment.
    Pavlovic S; Kotur N; Stankovic B; Zukic B; Gasic V; Dokmanovic L
    Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30832275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia.
    Gasic V; Zukic B; Stankovic B; Janic D; Dokmanovic L; Lazic J; Krstovski N; Dolzan V; Jazbec J; Pavlovic S; Kotur N
    Radiol Oncol; 2018 Sep; 52(3):296-306. PubMed ID: 30210047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial determinants of cancer health disparities.
    Choudhury AR; Singh KK
    Semin Cancer Biol; 2017 Dec; 47():125-146. PubMed ID: 28487205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia.
    Xue L; Li C; Wang Y; Sun W; Ma C; He Y; Yu Y; Cai L; Wang L
    Leuk Lymphoma; 2015 Jun; 56(6):1704-9. PubMed ID: 25644744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
    Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; van Rossum EF; van Wering ER; Koper JW; Sonneveld P; Pieters R
    Clin Cancer Res; 2005 Aug; 11(16):6050-6. PubMed ID: 16115950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Lauten M; Cario G; Asgedom G; Welte K; Schrappe M
    Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.
    Anderer G; Schrappe M; Brechlin AM; Lauten M; Muti P; Welte K; Stanulla M
    Pharmacogenetics; 2000 Nov; 10(8):715-26. PubMed ID: 11186134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations.
    Gaynon PS; Lustig RH
    J Pediatr Hematol Oncol; 1995 Feb; 17(1):1-12. PubMed ID: 7743230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of the structure of the glucocorticoid receptor and single nucleotide
    Brovkina SS; Dzherieva IS; Volkova NI; Shkurat TP; Goncharova ZA; Mashkina EV; Reshetnikov IB
    Probl Endokrinol (Mosk); 2023 Feb; 69(1):50-58. PubMed ID: 36842077
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.